Zhuoling An

1.2k total citations
83 papers, 830 citations indexed

About

Zhuoling An is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Zhuoling An has authored 83 papers receiving a total of 830 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Oncology and 13 papers in Infectious Diseases. Recurrent topics in Zhuoling An's work include Metabolomics and Mass Spectrometry Studies (21 papers), COVID-19 Clinical Research Studies (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Zhuoling An is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (21 papers), COVID-19 Clinical Research Studies (9 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Zhuoling An collaborates with scholars based in China, United States and Hong Kong. Zhuoling An's co-authors include Pengfei Li, Ting Hu, Jiuming He, Ruiping Zhang, Zeper Abliz, Yanhua Chen, Jinfa Bai, Yongmei Song, Jianghao Sun and Lijia Dong and has published in prestigious journals such as The Science of The Total Environment, Antimicrobial Agents and Chemotherapy and Journal of Chromatography A.

In The Last Decade

Zhuoling An

74 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhuoling An China 16 422 143 117 87 77 83 830
Junling Ren China 17 554 1.3× 89 0.6× 99 0.8× 44 0.5× 106 1.4× 44 972
Caixia Yan China 18 403 1.0× 84 0.6× 63 0.5× 62 0.7× 80 1.0× 51 1.0k
Chinmoy Ghosh India 16 237 0.6× 152 1.1× 99 0.8× 32 0.4× 39 0.5× 35 756
Li Ding China 14 162 0.4× 111 0.8× 90 0.8× 55 0.6× 57 0.7× 79 724
Sicheng Liang China 16 382 0.9× 92 0.6× 88 0.8× 25 0.3× 176 2.3× 53 801
Guan‐Yuan Chen Taiwan 19 441 1.0× 57 0.4× 204 1.7× 72 0.8× 52 0.7× 66 978
Jeffrey Sailstad United States 12 456 1.1× 119 0.8× 157 1.3× 70 0.8× 96 1.2× 18 1.3k
Denise Gonçalves Priolli Brazil 16 401 1.0× 165 1.2× 29 0.2× 78 0.9× 48 0.6× 65 953
Zhiguo Hou China 17 317 0.8× 44 0.3× 61 0.5× 97 1.1× 108 1.4× 46 675

Countries citing papers authored by Zhuoling An

Since Specialization
Citations

This map shows the geographic impact of Zhuoling An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhuoling An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhuoling An more than expected).

Fields of papers citing papers by Zhuoling An

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhuoling An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhuoling An. The network helps show where Zhuoling An may publish in the future.

Co-authorship network of co-authors of Zhuoling An

This figure shows the co-authorship network connecting the top 25 collaborators of Zhuoling An. A scholar is included among the top collaborators of Zhuoling An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhuoling An. Zhuoling An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ma, Zhuo, et al.. (2025). Thromboembolic and bleeding events associated with angiogenesis inhibitors in cancer patients. Expert Opinion on Drug Safety. 1–10. 1 indexed citations
3.
Zhou, Jun, et al.. (2025). Lipidomic machine learning predictor for progression of gastric cancer. Clinica Chimica Acta. 580. 120731–120731.
4.
5.
Zhang, Yi, Zhuo Ma, Yuhui Zhang, et al.. (2024). Anticancer drug-induced interstitial lung disease: a critical appraisal of clinical practice guidelines and consensus statements. Expert Opinion on Drug Safety. 1–9. 1 indexed citations
6.
Jian, Yuan, Yanru Zhang, Yin Wu, et al.. (2024). Paired comparisons of venetoclax concentration in cerebrospinal fluid, bone marrow, and plasma in acute leukemia patients. Clinical and Translational Science. 17(9). e70006–e70006. 1 indexed citations
7.
Zhang, Yi, Lan Zhang, Yichen Zhang, et al.. (2024). Prevalence of aggressive care among patients with cancer near the end of life: a systematic review and meta-analysis. EClinicalMedicine. 71. 102561–102561. 12 indexed citations
8.
Zhang, Yi, Xinrui Wang, Chong Huang, et al.. (2024). Nirmatrelvir–Ritonavir Reduced Mortality in Hospitalized Patients with COVID-19 During the Omicron Outbreak: Real-World Evidence from Beijing. Infection and Drug Resistance. Volume 17. 1367–1377. 1 indexed citations
9.
Li, Boyu & Zhuoling An. (2023). Flavin-containing Monooxygenases in the Brain and their Involvement in Neurodegeneration and Aging. 0(0). 0–0. 1 indexed citations
10.
Zhang, Yi, et al.. (2023). Phosphatidylinositol 3 kinase inhibitor-related pneumonitis: a systematic review and meta-analysis. Expert Review of Clinical Pharmacology. 16(9). 855–863. 2 indexed citations
11.
Yang, Hui, Zhaojian Wang, Ying Zhang, et al.. (2023). Clinical characteristics and factors for serious outcomes among outpatients infected with the Omicron subvariant BF.7. Journal of Medical Virology. 95(8). e28977–e28977. 3 indexed citations
12.
Yang, Hui, Zhaojian Wang, Chunguo Jiang, et al.. (2023). Oral azvudine for mild‐to‐moderate COVID‐19 in high risk, nonhospitalized adults: Results of a real‐world study. Journal of Medical Virology. 95(7). e28947–e28947. 16 indexed citations
13.
14.
15.
Ma, Zhuo, Yi Zhang, Min Zhu, et al.. (2022). Interstitial lung disease associated with anti-HER2 anti-body drug conjugates: results from clinical trials and the WHO's pharmacovigilance database. Expert Review of Clinical Pharmacology. 15(11). 1351–1361. 15 indexed citations
16.
Ma, Zhuo, Yi Zhang, Hao Li, et al.. (2022). Interstitial pneumonitis associated with EGFR/ ALK tyrosine kinase inhibitors used in non–small cell lung cancer: an observational, retrospective, pharmacovigilance study. Expert Opinion on Drug Safety. 22(3). 237–242. 6 indexed citations
17.
18.
19.
Liŭ, Dan, Zhuoling An, Pengfei Li, et al.. (2020). A targeted neurotransmitter quantification and nontargeted metabolic profiling method for pharmacometabolomics analysis of olanzapine by using UPLC-HRMS. RSC Advances. 10(31). 18305–18314. 8 indexed citations
20.
Chen, Yanhua, Ruiping Zhang, Yongmei Song, et al.. (2009). RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer. The Analyst. 134(10). 2003–2003. 185 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Junling Ren Breakdown of academic impact, for papers by Caixia Yan Breakdown of academic impact, for papers by Chinmoy Ghosh Breakdown of academic impact, for papers by Li Ding Breakdown of academic impact, for papers by Sicheng Liang Breakdown of academic impact, for papers by Guan‐Yuan Chen Breakdown of academic impact, for papers by Jeffrey Sailstad Breakdown of academic impact, for papers by Denise Gonçalves Priolli Breakdown of academic impact, for papers by Zhiguo Hou
Rankless by CCL
2026